Cite
HARVARD Citation
Abd-ellatef, G. et al. (2023). Corrigendum to 'Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein' [Pharmacol. Res. 175 (2022) 105975]. Pharmacological research. p. . [Online].